Albutec
Rostock, DE · Founded 2004 · 1 known investors
Find your way into Albutec
Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure. The platform is intended for use by doctors, nurses, and critical care medical teams treating liver patients.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Albutec do?
- Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure. The platform is intended for use by doctors, nurses, and critical care medical teams treating liver patients.
- Who are Albutec's investors?
- Albutec's investors include Fresenius Medical Care Ventures.
- Where is Albutec headquartered?
- Albutec is headquartered in Rostock, DE.